HELX Holdings
72 holdings in the fund's latest file; the data source updated it on Oct 8, 2026.
Top 25 Holdings
| # | Holding | Weight | Shares (as reported) | Value (as reported) |
|---|---|---|---|---|
| 1 | NATERA INC | 10.24% | 7,679 | $3.0M |
| 2 | GUARDANT HEALTH INC | 9.60% | 16,927 | $2.8M |
| 3 | KRYSTAL BIOTECH INC | 5.20% | 4,757 | $1.5M |
| 4 | ADAPTIVE BIOTECHNOLOGIES | 4.60% | 51,956 | $1.4M |
| 5 | TWIST BIOSCIENCE CORP | 4.44% | 8,465 | $1.3M |
| 6 | LIGAND PHARMACEUTICALS | 4.40% | 4,451 | $1.3M |
| 7 | BRIDGEBIO PHARMA INC | 2.94% | 13,129 | $873.1K |
| 8 | MEDPACE HOLDINGS INC | 2.69% | 1,321 | $798.2K |
| 9 | VERTEX PHARMACEUTICALS IN | 2.63% | 1,545 | $781.2K |
| 10 | UNITED THERAPEUTICS CORP | 2.63% | 1,430 | $779.4K |
| 11 | TRAVERE THERAPEUTICS INC | 2.55% | 14,143 | $755.8K |
| 12 | ELI LILLY & CO | 2.41% | 601 | $714.4K |
| 13 | VYLOR INC security match unconfirmed | 2.25% | 9,147 | $667.6K |
| 14 | REGENERON PHARMACEUTICALS | 2.01% | 805 | $597.4K |
| 15 | GRAIL INC | 2.00% | 4,456 | $592.2K |
| 16 | TEMPUS AI INC-CL A | 1.94% | 8,190 | $576.2K |
| 17 | REPLIGEN CORP | 1.88% | 3,332 | $557.2K |
| 18 | CAREDX INC | 1.70% | 8,000 | $504.3K |
| 19 | CHARLES RIVER LABORATORIE | 1.57% | 1,556 | $467.3K |
| 20 | ARGENX SE (ARGX.BR) | 1.56% | 494 | $463.7K |
| 21 | NEUROCRINE BIOSCIENCES IN | 1.48% | 3,058 | $438.7K |
| 22 | JAZZ PHARMACEUTICALS PLC | 1.38% | 1,769 | $409.0K |
| 23 | 10X GENOMICS INC-CLASS A | 1.20% | 4,683 | $356.4K |
| 24 | BIONTECH SE-ADR | 1.18% | 3,666 | $349.2K |
| 25 | PTC THERAPEUTICS INC | 1.07% | 5,009 | $316.7K |
Sector Weights
- Basic Materials: 2.28%
- Healthcare: 97.04%
- Technology: 0.68%
Country Weights
- United States: 90.05%
- Germany: 1.99%
- Netherlands: 1.98%
- United Kingdom: 1.84%
- Ireland: 1.36%
- Switzerland: 1.17%
- South Korea: 1.01%
- Denmark: 0.54%
- Other: 0.06%
Shares, value and weight are as reported in the file, dated by the data source's last update of it (not the date of the positions), never adjusted; a split warning appears only for a split close to or after that date, and its absence does not mean the count is on today's share basis. Weights as the fund reports them. Leveraged and inverse funds list swaps and cash, so weights can be negative or add up past 100.